CALABRESE LAURA | Elenco docenti

Cinotti, E., D'Onghia, M., Cartocci, A., Reguiai, Z., Fougerousse, A.C., Boulard, C., et al. (2026). Abrocitinib: 1-Year Real-Life Experience From the French OMCCI Registry. DERMATOLOGIC THERAPY, 2026(1) [10.1155/dth/9460391]. - dettaglio
D'Onghia, M., Rubegni, G., Manzo Margiotta, F., Calabrese, L., Lo Conte, S., Magliulo, M., et al. (2026). T2-Reg: a regional web registry on Th2-mediated diseases. ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 161(1), 1-7 [10.23736/S2784-8671.25.08315-X]. - dettaglio
Manzo Margiotta, F., Dini, V., Calabrese, L., Lazzeri, L., Conte, S.L., Magliulo, M., et al. (2025). Upadacitinib dose adjustment in moderate-to-severe atopic dermatitis: insights from a multicenter real-world study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT [10.1111/ddg.15908]. - dettaglio
Calabrese, L., D'Onghia, M., Cartocci, A., Hinojosa-Azaola, A., Torres-Ruiz, J., Lopalco, G., et al. (2025). Unfolding dermatological spectrum of Still’s disease: a cohort study from the International AIDA Network Still’s Disease Registry. RHEUMATOLOGY [10.1093/rheumatology/keaf512]. - dettaglio
Calabrese, L., Cartocci, A., Vitale, A., Martín-Nares, E., D'Onghia, M., Caggiano, V., et al. (2025). IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 43(10), 1753-1762 [10.55563/clinexprheumatol/i9hsfr]. - dettaglio